Alabama, Birmingham: Anindya Dutta, an Indian-American biochemist and renowned cancer researcher, has been named the recipient of the prestigious 2024 Rous–Whipple Award by the American Society for Investigative Pathology (ASIP). He will receive this honor during the ASIP Annual Meeting, which is scheduled for April 2025 in Portland, Oregon.

The Rous–Whipple Award, named after influential pathologists Francis Peyton Rous and George Whipple, is presented to individuals who have made remarkable contributions to the understanding of disease. It recognizes senior scientists for their exceptional achievements in research, education, mentorship, and leadership within the field of pathology.

Dutta, a respected professor and chair of genetics at the University of Alabama at Birmingham, is widely recognized for his pioneering discoveries. He is credited with the groundbreaking identification of extrachromosomal DNA circles in both normal and cancer cells, which have shown promise as potential blood biomarkers for cancer detection.

His research primarily explores the genomic instability of cancer cells and the significant role of noncoding RNAs in cancer and cellular differentiation. Christopher Moskaluk, who nominated Dutta for the award, commended his substantial impact, stating, "Dutta is a leader in two distinct areas of molecular biology, with a proven track record of impactful discoveries that have garnered international recognition."

Dutta's accolades include being named a fellow of the American Association for the Advancement of Science and receiving the Ranbaxy Award for his research on genome instability. He earned his MBBS from Medical Christian College in Vellore, India, a Ph.D. from The Rockefeller University in New York, completed postdoctoral research at Cold Spring Harbor Laboratory, New York, and received residency training at Brigham & Women's Hospital, Harvard Medical School.